Evolution and plasticity of CTL responses against HIV

Current Opinion in Immunology

Volumn 8, Issue 4, 1996, Pages 546-553

  Autran, Brigitte ^a   Hadida, Fabienne ^a   Haas, Gaby ^a  

^a Laboratoire d'Immunologie Cellulaire et Tissulaire CNRS URA 625   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE GENE; IMMUNOTHERAPY; INFECTION CONTROL; MATHEMATICAL MODEL; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

EID: 0030219573     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80045-8     Document Type: Article

References (71)

1. Paul WE. Can the immune response control HIV infection? Cell. 82:1995;177-182.
2. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. of outstanding interest Nature. 373:1995;123-126 Shows experimental data and mathematical analysis of the extraordinarily high rates of viral turnover and clearance as well as CD4 turnover after HIV-specific treatment with a protease inhibitor.
3. Wei W, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, et al. Viral dynamics in Human Immunodeficiency Virus type 1 infection. of outstanding interest Nature. 373:1995;117-122 This is an impressive study on viral dynamics in the course of antiretroviral treatment which complements work presented in [2].
4. + cells.
5. Zinkernagel RM. Are HIV-specific CTL responses salutary or pathogenic? Curr Biol. 7:1995;462-470.
6. Koup RA, Safrit JT, Cao Y, Andrews A, McLeod, Borkosky W, Farthing C, Ho DD. Temporal association of cellular immune responses with the initial control of viremia in primary Human Immunodeficiency Virus Type 1 Syndrome. J Virol. 68:1994;4650-4655.
7. + cytotoxic T lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 68:1994;6103-6110.
8. Safrit JT, Andrews CA, Zhu T, Ho DD, Koup RA. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J Exp Med. 179:1994;463-472.
9. Safrit JT, Lee AY, Andrews CA, Koup RA. A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients. J Immunol. 153:1994;3822-3830.
10. Lamhamedi-Cherradi S, Culmann-Penciolelli B, Guy B, Duong Ly T, Goujard C, Guillet JG, Gomard E. Different patterns of HIV-1-specific cytotoxic T lymphocyte activity after primary infection. AIDS. 9:1995;421-426.
11. + T cells with a predominant Vβ usage during the primary immune response to HIV. Nature. 370:1994;463-467.
12. + cell levels. J Infect Dis. 170:1994;775-781.
13. Hoffenbach A, Langlade-Demoyen P, Vilmer E, Dadaglio G, Michel F, Mayaud C, Autran B, Plata F. Very high frequencies of HIV specific cytotoxic T lymphocytes in humans. J Immunol. 142:1989;452-456.
14. Joly P, Guillon JM, Mayaud C, Plata F, Theodorou I, Denis M, Debre P, Autran B. Cell mediated suppression of HIV-specific cytotoxic T lymphocytes. J Immunol. 143:1989;2193-2201.
15. Gotch FM, Nixon DF, Alp N, McMichael AJ, Borysievicz LK. High frequency of memory and effector Gag-specific cytotoxic T lymphocytes in HIV seropositive individuals. Int Immuno. 2:1990;707-712.
16. Rivière Y, McChesney MB, Porrot F, Tanneau-Salvadori F, Sansonetti P, Lopez O, Pialoux G, Feuillie V, Mollereau M, Chamaret S, et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. of special interest AIDS Res Hum Retroviruses. 118:1995;903-907 One of those rare studies that can show a correlation between CTL recognition and lack of disease progression.
17. Hadida F, Haas G, Zimmermann N, Hosmalin A, Spohn R, Jung R, Debré P, Autran B. Cytotoxic T lymphocytes from lymphoid organs recognize an optimal HLA-A2 and -B52 restricted nonpeptide and several epitopes in the C-terminal region of HIV-1 Nef. of special interest J Immunol. 154:1995;4174-4186 In this study a new CTL epitope is defined in the carboxy-terminal region of Nef as recognized in the context of several HLA-A2 subtypes; the functional definition correlates with findings of CTL recognition in the context of several HLA-A2 subtypes.
18. + T lymphocytes in spleens of human immunodeficiency virus-positive patients. of special interest J Virol. 69:1995;4737-4745 A study based on limiting dilution polymerase chain reactions showing that a very small fraction of dendritic are infected with HIV in the lymphoid organs.
19. + positive cytotoxic lymphocytes in Acquired Immunodeficiency Syndrome lymphomas. of special interest Hum Pathol. 26:1995;284-290 This study indicates that primed CTL effectors persist in lymphoid organs and tumors in AIDS patients and suggest that at this stage the Th1 defect does not impair amplification and persistence of effector CTLs in vivo.
20. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 234:1986;1563-1565.
21. + T cells. Science. 270:1995;1811-1815.
22. Toso JF, Chen CH, Mohr JR, Piglia L, Oei C, Ferrari G, Greenberg ML, Weinhood KJ. Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication. J Infect Dis. 172:1995;964-973.
23. + cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism. J Immunol. 153:1995;4826-4833.
24. Moss PAH, Rowland-Jones SL, Frodsham PM, McAdam S, Giangrande P, McMichael AJ, Bell JI. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. of special interest Proc Natl Acad Sci USA. 92:1995;5773-5777 This study shows frequencies of TCR CDR3 subsets of HIV-specific CTLs using a polymerase chain reaction limiting-dillution technique.
25. Klein MR, VanBaalen CA, Holwerda AM, Garde KSR, Bende RJ, Keet IPM, Eeftinck-Schattenkerk JKM, Osterhaus ADME, Schuitemaker H, Miedema F. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. of special interest J Exp Med. 181:1995;1365-1372 A comparative study to determine factors for rapid disease progression.
26. Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo HS, D'aguila RT, Kurnick JT, Walker BD. Longitudinal analysis of T cell receptor (TCR) gene usage by Human Immunodeficiency Virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med. 179:1994;1261-1271.
27. Cheynier R, Henrichwark S, Hadida F, Pelletier E, Oksenhendler E, Autran B, Wain-Hobson W. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell. 78:1994;373-387.
28. Greenough TC, Somasundaran M, Brettler DB, Hesselton RM, Alimenti A, Kirschoff F, Panicali D, Sullivan JL. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses. 10:1994;395-403.
29. Harrer E, Harrer T, Buchbinder S, Mann DL, Feinberg M, Yilma T, Johnson RP, Walker BD. HIV-1 specific cytotoxic T lymphocyte response in healthy long-term nonprogressing seropositive persons. (suppl 2) AIDS Res Hum Retrovirus. 10:1994;77-78.
30. Rinaldo C, Huang XL, Fan ZF, Ding M, Beltz L, Logar A, Panicali D, Mazzara G, Liebman J, Cottril M. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long-term nonprogressors. of outstanding interest J Virol. 69:1995;5838-5842 A study that succeeds in correlating low viral load, strong CTL activity and slow disease progression.
31. Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. of special interest J Immunol. 156:1996;2616-2623 The characterization of HIV-specific CTLs in LTNPs shows that CTLs recognize multiple HIV proteins or epitopes and that a high viral load may not be required to generate a strong CTL response.
32. + lymphocyte activity. of outstanding interest J Infect Dis. 172:1995;329-339 An extensive virological and immunological study delineating the heterogenecity among AIDS patients, nonprogressors and long-term survivors at the CTL level and defining differences between them.
33. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, Winkler C, OBrien SJ, Rinaldo C, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. of outstanding interest Nat Med. 24:1996;405-411 A major study linking several HLA class I or class II alleles with a slow rate of disease progression in a subset of the MACS cohort. These promising results strengthen our belief in the role of immune responses in determining favourable outcomes.
34. Cheynier R, Langlade-Demoyen P, Marescot MR, Blanche S, Blondin G, Wain-Hobson S, Griscelli C, Vilmer E, Plata F. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1 infected mothers. Eur J Immunol. 22:1992;2211-2217.
35. Buseyna F, Janvier G, Fleury B, Schmidt D, Rivière Y. Multispecific and heterogeneous recognition of the gag protein by cytotoxic T lymphocytes (CTL) from HIV-infected patients: factors other than the MHC control the epitopic specificities. Clin Exp Immunol. 97:1994;353-360.
36. Luzuriaga K, Holmes D, Hereema A, Wong J, Panicali DL, Sullivan JL. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. of outstanding interest J Immunol. 154:1995;433-443 An important study of HIV-specific CTLs in children the results indicate that CTL responses were not detectable in exposed, noninfected infants.
37. De Maria A, Cirillo C, Moretta L. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J Infect Dis. 170:1994;1296-1299.
38. McFarland EJ, Harding PA, Luckey D, Convay B, Young RK, Kuritzkes DR. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection. J Infect Dis. 170:1994;766-774.
39. Froebel KS, Aldhous MC, Mok JY, Hayley J, Arnott M, Peutherer JF. Cytotoxic T lymphocyte activity in children infected with HIV. (suppl 2) AIDS Res Hum Retroviruses. 10:1994;83-88.
40. Rowland-Jones SL, McMichael A. Immune responses in HIV-exposed seronegatives: have they repelled the virus? of special interest Curr Biol. 7:1995;448-455 A review that critically comments on some evidence for the existence of resistance against HIV infection.
41. Kroner BL, Goedert JJ, Blattner WA, Wilson SE, Carrington MN, Mann DL. Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. AIDS. 9:1995;275-280.
42. McGuire W, Hill AVS, Allsopp CE, Greenwood CE, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508-510.
43. Franco A, Ferrari C, Sette A, Chisari FV. Viral mutations, TCR antagonism and escape from the immune response. of outstanding interest Curr Biol. 7:1995;524-531 Reviews different mechanisms of how viruses may avoid immune recognition.
44. Schwartz O, Maréchal V, LeGall S, Lemonnier F, Heard JM. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. of special interest Nat Med. 2:1996;338-342 A paper showing the properties of the HIV Nef protein from various viral isolates that lead to impaired MHC expression on the cell surface in vitro and may also have implications for CTL recognition in vivo.
45. Matsui M, Warburton RJ, Cogswell PC, Baldwin AS, Frelinger JA. Effects of HIV-1 Tat on expression of HLA class I molecules. J Acquir Immune Defic Syndr Hum Retrovirol. 11:1996;233-240.
46. Couillin I, Culmann-Penciolelli B, Gornard E, Choppin J, Levy JP, Guillet JG, Saragosti S. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic regions of the Human Immunodeficiency Virus 1 Nef protein. J Exp Med. 180:1994;1129-1134.
47. Jameson SC, Bevan MJ. T cell receptor antagonists and partial agonist. of special interest Immunity. 2:1995;1-11 Complete review on different properties of TCR antagonism.
48. Alexander-Miller M, Parker K, Tsukui C, Pendleton C, Coligan J, Berzofsky A. P18-specific, HLA-A2 restricted and H-2Dd restricted CTLs share a common minimal epitope which utilizes residues for MHC [abstract]. a(suppl) J Cell Biochem. 21:1995;135.
49. Klenerman P, Rowland-Jones S, Mcadam S, Edwards J, Daenke S, Lailoo D, Köppe B, Rosenberg W, Boyd D, Edwards A, et al. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature. 369:1994;403-410.
50. Klenerman P, Meier UC, Phillips RE, McMichael AJ. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur J Immunol. 25:1995;1927-1931.
51. Meier UC, Klenerman P, Griffin P, James W, Koppe B, Larder B, McMichael A, Phillips R. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. of special interest Science. 270:1995;1360-1362 Some RT viral variants have been found to induce antagonistic effects by the inhibition of CTL recognition of wild-type peptides without affecting viral viability.
52. Haas G, Debré P, Dudoit Y, Bonduelle O, Katlama C, Maier B, Plikat U, Meyerhans A, Ihlenfeldt HG, Jung G, Autran B. Time course adaptation of HIV-1 Nef-specific CTL to epitope variations [abstract]. of special interest J Cell Biochem. 21a:1995;142 This study indicates that viral variant persistence is mostly transient and may create successive waves of new variants and specific CTLs.
53. Nietfield W, Bauer M, Fevrier M, Maier R, Holzwarth B, Frank R, Maier B, Riviere Y, Meyerhans A. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope. of special interest J Immunol. 1995;2188-2197 Some HIV Gag viral variants that are not recognized by specific CTLs result in reduced viral infectivity.
54. Pelletier E, Saurin W, Cheynier R, Letvin NL, Wain-Hobson S. The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance. Virology. 208:1995;644-652.
55. Nowak MA, May RM, Phillips RE, Rowland-Jones S, Lalloo D, McAdam S, Klenerman P, Köppe B, Sigmund K, Bangham CRM, McMichael AJ. Antigenic oscillations and shifting immunodominance in HIV-1 infections. of outstanding interest Nature. 375:1995;606-611 The authors predict using a mathematical model that fluctuations in HIV viral variation and CTL responses are a function of immunodominance of viral epitopes.
56. Nowak MA, Bangham CR. Population dynamics of immune responses to persistent viruses. of outstanding interest Science. 272:1996;74-79 Additional model to suggest the impact of CTL responsiveness to and recognition of viral epitopes on viral load and disease progression in HIV-1 and HIV infections.
57. + patient. Am J Pathol. 146:1995;1542-1555.
58. + T lymphocytes from AIDS and immunosuppressed bone marrow recipients. Eur J Immunol. 24:1994;2882-2888.
59. + T cells by increased rounds of cell division.
60. Fiorentino S, Dalod M, Olive D, Guillet JG, Gornard E. Predominant involvement of CD8(+) CD28(-) lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J Virol. 70:1996;2022-2026.
61. + T lymphocytes during HIV infection. J Immunol. 156:1996;2282-2293.
62. + T cells from HIV-infected persons. J Immunol. 153:1994;412-420.
63. + T cells are susceptible to Fas-mediated apoptosis and may undergo antigen-induced cell death in vivo.
64. Chia WK, Freedman J, Li X, Salit I, Kardish M, Read SE. Programmed cell death induced by HIV type 1 antigen stimulation is associated with a decrease in cytotoxic T lymphocyte activity in advanced HIV type 1 infection. AIDS Res Hum Retrov. 11:1995;249-256.
65. + cell decline, chronic CTL activation and antibody production with implications for antiretroviral therapy (with a need for specific stimulation at low viral load).
66. Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI. Human immunodeficiency virus type 1 evolution in vivo tracker by DNA heteroduplex mobility assays. J Virol. 68:1994;6672-6683.
67. Wolinsky SM, Korber BTM, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, Furtado MR, Cao Y, Do DD, Safrit JT, Koup RA. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. of outstanding interest Science. 272:1996;537-542 Demonstrates the presence of specific CTLs and highly diverse virus types in nonprogressors, while rapid progressors show low diversity and no specific CTLs.
68. Phillip AN. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science. 271:1996;497-499. of special interest.
69. Koenig S, Conley AJ, Brewah YA, Jones GM, Leath S, Boots LJ, Davey V, Pantaleo G, Demarest JF, Carter C, et al. Transfer of HIV-1 specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. of outstanding interest Nat Med. 4:1995;330-336 A passive HIV-specific CTL transfer study in a single HIV progressor using expanded in vitro CTL clones. Continuing disease progression and induction of a massive escape phenomenon demostrate the limits of immune therapy based upon a clonal CTL approach and its potentially deleterious effects.
70. Riddell ST, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, Manley SA, Lupton SD, Overell RW, Reynolds RC, Corey L, Greenberg PD. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. of outstanding interest Nat Med. 2:1996;216-223 A passive HIV-specific CTL transfer study in progressors using Gag-specific CTL clones transfected with the TK suicide gene. Transfer-induced potent TK-specific CTL activity that prompted rapid elimination of the transferred CTLs, thus demonstrating the capacity to prime new CTLs in vivo in progressors.
71. Lieberman J, Fabry JA, Shankar P, Beckett J, Skolnik PR. Ex vivo expansion of HIV type-1 specific cytolytic T cells from HIV type 1-seropositive subjects. of outstanding interest AIDS Res Hum Retroviruses. 11:1995;257-271 Transfer of HIV-specific CTLs does not induce major side effects or negative impact on disease progression like the transfer of a single clone in [69].